Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.
 
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | total n=
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | total n=
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1075 1376
Bimekizumab 344 0
Brodalumab 580

0
Certolizumab 226 0
Efalizumab 35 0
Etanercept 312 72
Golimumab 25 0
Guselkumab 1776 0
Infliximab 103 1
Ixekizumab 996 0
Risankizumab 1706 0
Secukinumab 2073 0
Tildrakizumab 1519 0
Ustekinumab 778 0
Apremilast 752 0
Ciclosporin 402 0
Fumaderm® 2694 0
Skilarence® 3292 0
Methotrexat 3922 0
Tofacitinib 2 0
Upadacitinib 5 0
Deucravacitinib 162 0
other systemics 356 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | total n=
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | total n=
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers